EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxeiptosis – potential in cancer treatment?

Mateusz Kciuk iD, Katarzyna Wanke iD, Żaneta Kałuzińska-Kołat iD, Renata Kontek iD

Expert Reviews in Molecular Medicine · 2026

DOI: 10.1017/erm.2026.10045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, 2026. Verfasst von Mateusz Kciuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Neoplasms, Antineoplastic Agents, Apoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxeiptosis is a reactive oxygen species (ROS)-dependent form of programmed cell death that plays a key role in cellular homeostasis and holds promise as a cancer therapy. This review explores its molecular mechanisms, emphasizing the KEAP1–PGAM5–AIFM1 signalling pathway and its reliance on ROS accumulation. Compared to other cell death pathways, oxeiptosis offers a distinct approach, especially for targeting cancer cells resistant to conventional therapies. The review evaluates emerging inducers, both synthetic and natural, that selectively trigger oxeiptosis in cancer cells. It also examines the potential synergy between oxeiptosis and ROS-generating chemotherapies, particularly in the oxidative tumour microenvironment. However, challenges remain, including identifying tumour-specific inducers, overcoming cancer cell resistance to oxidative stress and reducing off-target effects. The review concludes by highlighting the need for targeted delivery strategies and rigorous preclinical studies to translate oxeiptosis into effective cancer treatments. Overall, it underscores oxeiptosis as a promising avenue to address drug resistance and improve therapeutic outcomes in oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesNeoplasmsAntineoplastic AgentsApoptosisHumansOxidative StressAnimalsSignal TransductionTumor MicroenvironmentDrug Resistance, Neoplasm

Stichwörter der Autor:innen

cell deathchemotherapyoxeiptosisoxidative stressreactive oxygen species (ROS)

Substanzen

Reactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
  • Doctoral School of Exact and Natural Sciences, University of Lodz, Lodz, Poland.
  • Department of Functional Genomics, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.

ORCID-Profile: Mateusz Kciuk, Katarzyna Wanke, Żaneta Kałuzińska-Kołat, Renata Kontek

Zitieren

APA

Kciuk, M., Wanke, K., Kałuzińska-Kołat, Ż., & Kontek, R. (2026). Oxeiptosis – potential in cancer treatment?. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/erm.2026.10045

Vancouver

Kciuk M, Wanke K, Kałuzińska-Kołat Ż, Kontek R. Oxeiptosis – potential in cancer treatment?. Expert Reviews in Molecular Medicine. 2026. doi:10.1017/erm.2026.10045

BibTeX
@article{Kciuk2026,
  author = {Kciuk, Mateusz and Wanke, Katarzyna and Kałuzińska-Kołat, Żaneta and Kontek, Renata},
  title = {Oxeiptosis – potential in cancer treatment?},
  journal = {Expert Reviews in Molecular Medicine},
  year = {2026},
  doi = {10.1017/erm.2026.10045}
}
Kostenlos starten →